MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Depression in Parkinson’s disease is associated with subcortical neurodegeneration and increased risk of all-cause mortality and dementia

    J. Badenoch, A. Paris, B. Jacobs, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

  • Depression profile in Mexican patients with Parkinson Disease: a cross-sectional study

    P. Reyes-Pérez, A. Medina-Rivera, A. Ruiz-Contreras, S. Alcauter-Solorzano, M. Rentería, A. Lazaro-Figueroa, Y. Matuk-Pérez, N. Gandarilla-Martínez, K. Salinas-Barboza, I. Estrada-Bellmann (Queretaro, Mexico)

  • Describing the syndrome: a comprehensive analysis of a large cohort of corticobasal syndrome with pathological correlation

    D. Vaughan, M. Theilmann Jensen, D. Lux, L. Wu, Z. Jaunmuktane, T. Revesz, T. Lynch, M. Stamelou, K. Seppi, R. Vandenberghe, T. Warner, K. Bhatia, A. Lees, A. Church, N. Leigh, P. Taba, T. Matsalu, P. Mir, B. Ghosh, M. Picillo, J. Wallin, P. Svenningsson, Y. Compta, J. Rohrer, J. Rowe, H. Morris (London, United Kingdom)

  • Description of a series of GAA-FGF14 ataxia / SCA27b patients

    P. Iruzubieta, D. Pellerin, J. Ruiz, A. Bergareche, E. Mondragon, I. Albajar, J. Equiza, G. Nuñez, P. Arratibel, F. Moreno, J. Poza, M. Ruibal, R. Fernández-Torrón, A. Vinagre, I. Croitoru, M. Dicaire, B. Brais, H. Houlden, A. Lopez Munain (San Sebastián, Spain)

  • Design of a Phase 2 Study of Suvecaltamide in Moderate to Severe Parkinson’s Disease Tremor

    R. Hauser, C. Adler, G. Deuschl, M. Baladi, P. Chandler, T. Skarpass, K. Xu, P. Lewitt (Tampa, USA)

  • Design of a time-to-event study in GBA Parkinson’s Disease patients: Efficacy and safety of BIA 28-6156, an allosteric activator of beta-glucocerobridase (GCase)

    L. Magalhães, M. Fonseca, G. Castilla-Fernández, R. Costa, D. Simon, J. Holenz, N. Mendonça (Coronado, Portugal)

  • Detailed illustration of a Turkish patient with homozygous C19ORF12 mutation

    H. Onder, T. Comoglu, S. Comoglu (Ankara, Turkey)

  • Detecting Changes in Parkinson’s Motor Symptom Patterns Using Wearable Devices

    A. Arnold, A. Hare, W. Chen, T. Jansen, R. Gilron (San Francsico, USA)

  • Detecting clinical fluctuations in chronic biomarker recordings: experiences with chronic subthalamic peak beta band recordings in a large Parkinson’s disease patient cohort

    LK. Feldmann, J. Habets, V. D'Onofrio, V. Mathiopoulou, J. Busch, K. Faust, GH. Schneider, D. Gruber, G. Ebersbacher, AA. Kühn (Berlin, Germany)

  • Detection and classification of GBA variants PD-related: is there sex unbalance?

    C. Reale, C. Panteghini, I. Colangelo, M. Suerz, R. Cilia, R. Eleopra, B. Garavaglia, F. Invernizzi (Milan, Italy)

  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley